We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
PG Raises Sales Outlook as Thorne Acquisition Adds Growth Potential
Read MoreHide Full Article
Key Takeaways
PG raised its fiscal 2027 sales growth outlook to 2-4% after completing the Thorne acquisition.
Organic sales growth guidance remains at 1-3%, while core earnings growth is projected at 0-3%.
Rising financing costs, commodity pressures and restructuring risks may limit the Thorne deal's benefits.
The Procter & Gamble Company (PG - Free Report) raised its fiscal 2027 all-in sales growth outlook after completing the Thorne acquisition, adding a new source of reported growth. The revision lifts the top-line range, but it does not change the company’s underlying organic sales expectations.
That distinction matters because PG is absorbing higher financing and operating costs while executing a broader restructuring program. The acquisition can support reported sales growth, but its earnings contribution will depend on integration, cost control and capital efficiency.
PG's Thorne Deal Lifts Reported Growth
PG raised its fiscal 2027 all-in sales growth guidance to 2-4% from 1-3%, reflecting the Thorne acquisition, which closed on Oct. 1, 2026. The updated range indicates that acquisition activity is expected to add to reported sales growth during the year.
The company maintained its fiscal 2027 core earnings growth outlook at 0-3%, implying earnings of $6.89-$7.11 per share. That unchanged earnings range keeps the near-term focus on how effectively incremental sales translate into profit as the acquired business is incorporated.
PG's Organic Outlook Remains Unchanged
Management kept fiscal 2027 organic sales growth guidance at 1-3%, even after PG delivered 4% organic growth in the fiscal first quarter. The outlook also includes a 30-50-basis-point headwind from brand, product-form and go-to-market discontinuations.
Consumer-health peers offer useful context for the broader demand environment. Colgate-Palmolive Company (CL - Free Report) reported 3.6% organic sales growth in the third quarter of 2026, while Haleon plc (HLN - Free Report) posted 2.6% organic revenue growth. PG’s guidance therefore remains measured despite stronger first-quarter performance.
Procter & Gamble Company (The) Price, Consensus and EPS Surprise
PG expects about $300 million in after-tax headwinds from higher net interest expense in fiscal 2027, partly reflecting debt financing tied to recent acquisition activity. Management also forecasts a $50 million after-tax foreign-exchange headwind and $150 million from lower non-operating income.
These pressures sit alongside about $1.4 billion in after-tax commodity, energy and transportation cost headwinds. Combined, the identified earnings pressures equate to 79 cents per share, or an 11% drag on fiscal 2027 core earnings growth.
PG's Integration Adds Execution Risk
The Thorne acquisition arrives while PG is carrying out a portfolio and organizational restructuring program. The company expects $2 billion in pretax restructuring costs over two years, with the remaining portion scheduled for fiscal 2027 after more than half was incurred in fiscal 2026.
The program includes operational streamlining, selected product discontinuations and go-to-market changes. Those efforts may improve efficiency over time, but they also create execution demands as PG integrates an acquired business while protecting productivity, margins and returns on invested capital.
PG's Signals Keep the Event in Perspective
The acquisition raises PG’s reported sales outlook, but unchanged organic growth and core earnings guidance keep the near-term benefit in perspective. Financing costs and restructuring execution remain important offsets to the incremental revenue contribution.
PG carries a Zacks Rank #3 (Hold). It also has a VGM Score of D, a Value Score of D, a Growth Score of C and a Momentum Score of D.
Style Scores complement the Zacks Rank by assessing different stock characteristics, and the current mix points to a less favorable value and momentum profile than growth. Together, the signals support a measured view while investors assess how the Thorne deal affects earnings and returns over time.
Image: Bigstock
PG Raises Sales Outlook as Thorne Acquisition Adds Growth Potential
Key Takeaways
The Procter & Gamble Company (PG - Free Report) raised its fiscal 2027 all-in sales growth outlook after completing the Thorne acquisition, adding a new source of reported growth. The revision lifts the top-line range, but it does not change the company’s underlying organic sales expectations.
That distinction matters because PG is absorbing higher financing and operating costs while executing a broader restructuring program. The acquisition can support reported sales growth, but its earnings contribution will depend on integration, cost control and capital efficiency.
PG's Thorne Deal Lifts Reported Growth
PG raised its fiscal 2027 all-in sales growth guidance to 2-4% from 1-3%, reflecting the Thorne acquisition, which closed on Oct. 1, 2026. The updated range indicates that acquisition activity is expected to add to reported sales growth during the year.
The company maintained its fiscal 2027 core earnings growth outlook at 0-3%, implying earnings of $6.89-$7.11 per share. That unchanged earnings range keeps the near-term focus on how effectively incremental sales translate into profit as the acquired business is incorporated.
PG's Organic Outlook Remains Unchanged
Management kept fiscal 2027 organic sales growth guidance at 1-3%, even after PG delivered 4% organic growth in the fiscal first quarter. The outlook also includes a 30-50-basis-point headwind from brand, product-form and go-to-market discontinuations.
Consumer-health peers offer useful context for the broader demand environment. Colgate-Palmolive Company (CL - Free Report) reported 3.6% organic sales growth in the third quarter of 2026, while Haleon plc (HLN - Free Report) posted 2.6% organic revenue growth. PG’s guidance therefore remains measured despite stronger first-quarter performance.
Procter & Gamble Company (The) Price, Consensus and EPS Surprise
Procter & Gamble Company (The) price-consensus-eps-surprise-chart | Procter & Gamble Company (The) Quote
PG's Financing Costs Offset Some Benefits
PG expects about $300 million in after-tax headwinds from higher net interest expense in fiscal 2027, partly reflecting debt financing tied to recent acquisition activity. Management also forecasts a $50 million after-tax foreign-exchange headwind and $150 million from lower non-operating income.
These pressures sit alongside about $1.4 billion in after-tax commodity, energy and transportation cost headwinds. Combined, the identified earnings pressures equate to 79 cents per share, or an 11% drag on fiscal 2027 core earnings growth.
PG's Integration Adds Execution Risk
The Thorne acquisition arrives while PG is carrying out a portfolio and organizational restructuring program. The company expects $2 billion in pretax restructuring costs over two years, with the remaining portion scheduled for fiscal 2027 after more than half was incurred in fiscal 2026.
The program includes operational streamlining, selected product discontinuations and go-to-market changes. Those efforts may improve efficiency over time, but they also create execution demands as PG integrates an acquired business while protecting productivity, margins and returns on invested capital.
PG's Signals Keep the Event in Perspective
The acquisition raises PG’s reported sales outlook, but unchanged organic growth and core earnings guidance keep the near-term benefit in perspective. Financing costs and restructuring execution remain important offsets to the incremental revenue contribution.
PG carries a Zacks Rank #3 (Hold). It also has a VGM Score of D, a Value Score of D, a Growth Score of C and a Momentum Score of D.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Style Scores complement the Zacks Rank by assessing different stock characteristics, and the current mix points to a less favorable value and momentum profile than growth. Together, the signals support a measured view while investors assess how the Thorne deal affects earnings and returns over time.